These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35425620)

  • 1. Workplace influenza vaccination in private hospital setting: a cost-benefit analysis.
    Tohiar MAH; Jaafar S; Aizuddin AN; Leong TK; Abdul Rahim AS
    Ann Occup Environ Med; 2022; 34():e3. PubMed ID: 35425620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workplace vaccination against influenza in Malaysia: does the employer benefit?
    Samad AH; Usul MH; Zakaria D; Ismail R; Tasset-Tisseau A; Baron-Papillon F; Follet A
    J Occup Health; 2006 Jan; 48(1):1-10. PubMed ID: 16484757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Cost Effectiveness of Influenza Vaccination for Emergency Medical Services Professionals.
    Hubble MW; Renkiewicz GK
    West J Emerg Med; 2021 Oct; 22(6):1317-1325. PubMed ID: 34787557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective.
    Morales A; Martinez MM; Tasset-Tisseau A; Rey E; Baron-Papillon F; Follet A
    Value Health; 2004; 7(4):433-41. PubMed ID: 15449635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
    Verelst F; Beutels P; Hens N; Willem L
    Vaccine; 2021 Apr; 39(14):2005-2015. PubMed ID: 33632564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review.
    Blanchet Zumofen MH; Frimpter J; Hansen SA
    Pharmacoeconomics; 2023 Mar; 41(3):253-273. PubMed ID: 36515814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination and absenteeism among healthy working adults: a cost-benefit analysis.
    Ferro A; Bordin P; Benacchio L; Fornasiero F; Bressan V; Tralli V; Moretti F; Majori S
    Ann Ig; 2020; 32(3):234-244. PubMed ID: 32266361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers.
    Imai C; Toizumi M; Hall L; Lambert S; Halton K; Merollini K
    PLoS One; 2018; 13(6):e0198685. PubMed ID: 29879206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-benefit analysis of Wisconsin's screening, brief intervention, and referral to treatment program: adding the employer's perspective.
    Quanbeck A; Lang K; Enami K; Brown RL
    WMJ; 2010 Feb; 109(1):9-14. PubMed ID: 20942294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluations of interventions against influenza at workplaces: systematic review.
    Ofori SK; Hung YW; Schwind JS; Diallo K; Babatunde D; Nwaobi SO; Hua X; Sullivan KL; Cowling BJ; Chowell G; Fung ICH
    Occup Med (Lond); 2022 Feb; 72(2):70-80. PubMed ID: 34931675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic costs of influenza-related work absenteeism.
    Akazawa M; Sindelar JL; Paltiel AD
    Value Health; 2003; 6(2):107-15. PubMed ID: 12641861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
    Burckel E; Ashraf T; de Sousa Filho JP; Forleo Neto E; Guarino H; Yauti C; Barreto F de B; Champion L
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):563-76. PubMed ID: 10662481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
    Lee BY; Bailey RR; Wiringa AE; Afriyie A; Wateska AR; Smith KJ; Zimmerman RK
    Vaccine; 2010 Aug; 28(37):5952-9. PubMed ID: 20620168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-benefit of an influenza vaccination program for health care workers.
    Yassi A; Kettner J; Hammond G; Cheang M; McGill M
    Can J Infect Dis; 1991; 2(3):101-8. PubMed ID: 22529718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of the influenza vaccine in a healthy, working-age population.
    Campbell DS; Rumley MH
    J Occup Environ Med; 1997 May; 39(5):408-14. PubMed ID: 9172085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative value of various employer-sponsored influenza vaccination clinics.
    Zimmerman RK; Wiringa AE; Nowalk MP; Lin CJ; Rousculp MD; Mitgang EA; Lee BY
    J Occup Environ Med; 2012 Sep; 54(9):1107-17. PubMed ID: 22929797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A worksite influenza immunization program. Impact on lost work days, health care utilization, and health care spending.
    Dille JH
    AAOHN J; 1999 Jul; 47(7):301-9. PubMed ID: 10661043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.